During the 8th International Thymic Malignancy Interest Group Annual Meeting (ITMIG 2017) held in Torino, Italy, Prof. Patrick Loehrer from the Indiana University Melvin and Bren Simon Cancer Center presented his perspectives at a panel discussion on the topic “How do we Choose our Therapies and Future Trial Designs in TET?” as an invited speaker. After the session, we were honored to conduct an interview with Prof. Loehrer.
